Lite Strategy, Inc. — Director's Dealing 2019

Oct 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2019-09-27

Reporting Person: GOLD DANIEL P PHD (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-27	Common Stock	M	20000	$1.57	Acquired	342882	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-27	Stock Option (Right to Buy)	$1.57	M	20000	Disposed	2025-07-28	Common Stock (20000)	Direct

Footnotes

F1: All of the options are fully vested and currently exercisable.